FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Dilip Davda recommend to "Avoid" the IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 0 | 0 | 1 | 0 |
% | 0.00 | 0.00 | 0.00 | 100.00 | 0.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Dilip Davda | Avoid |
[Dilip Davda] After the average performance for FY21 and FY22 (standalone basis), it marked miraculous profits for FY23 on a standalone and consolidated basis. This not only raises eyebrows, but concerns over the sustainability going forward. One more surprise is the hike in the issue size in just a few days as can be seen from RHP dated 01.05.23 and 06.05.23. Considering this, the issue lacks transparency and is aggressively priced discounting all near-term positives. There is no harm in skipping this pricey IPO. Read detail review...
Auro Impex & Chemicals IPO Reviews, analysis and views by popular members. Read Auro Impex & Chemicals Limited IPO reviews by retail investors to find recommended ipo to buy.
Post Recommendation Manage Your IPO Reviews
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 2 | 0 | 0 | 1 |
% | 66.67 | 0.00 | 0.00 | 33.33 |
Member | Review |
---|---|
Baron |
Avoid Huge borrowings fake gmp total avoid |
judo |
Apply for Listing Gain at Upper Price Band must apply great 230 cr company May 10, 2023 3:03:14 PM |
Mukesh Pandya |
Apply for Listing Gain at Cut-off Price Good company May 5, 2023 12:12:53 PM |
Post Recommendation Manage Recommendations
Note:
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|